Researchers assess the differences in out-of-pocket spending on brand name compared with generic medication.
|Articles|October 18, 2007
Coalition wants e-prescribing in Medicare to be mandatory by 2010
Groups press for e-prescribing in Medicare.
Advertisement
A broad coalition of consumer, union, business, and purchaser groups is urging Congress to make e-prescribing in Medicare mandatory for all doctors by 2010. In a letter to Congressional committee leaders, the coalition urged policymakers to implement a safety requirement that
Advertisement
Related to this article
Practical takeaways to improve real‑world clinic outcomes for PAINWeek 2026.
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
The trial found that up to 25 days of nirmatrelvir-ritonavir did not improve cognitive, autonomic, or exercise-related symptoms compared with placebo.
Digital innovation and proactive patient care are converging to transform clinical practice while preserving essential safeguards.
James Barnes, CPhT, explains why respecting a patient's time isn't about speed and how he landed in the pharmacy by chance.
ACIP changes, new court rulings, and coverage gaps threaten vaccines, pharmacists’ reimbursement, and children's access through Vaccine For Children.
As pouched products increase in popularity, researchers assess their pharmacology, harm-reduction potential, and initiation risk.
Advertisement
Advertisement
Trending on Drug Topics
1
Nicotine Pouches Create Opportunity for Pharmacist Counseling
2
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
3
Worth a Shot: How ACIP Changes Might Impact Vaccine Access, Coverage
4
Nirmatrelvir-Ritonavir Shows No Benefit for Long COVID
5